Podchaser Logo
Home
58. Deuterium Depletion for Cancer & Diabetes with Dr Gabor Somlyai

58. Deuterium Depletion for Cancer & Diabetes with Dr Gabor Somlyai

Released Saturday, 24th February 2024
Good episode? Give it some love!
58. Deuterium Depletion for Cancer & Diabetes with Dr Gabor Somlyai

58. Deuterium Depletion for Cancer & Diabetes with Dr Gabor Somlyai

58. Deuterium Depletion for Cancer & Diabetes with Dr Gabor Somlyai

58. Deuterium Depletion for Cancer & Diabetes with Dr Gabor Somlyai

Saturday, 24th February 2024
Good episode? Give it some love!
Rate Episode

Episode Transcript

Transcripts are displayed as originally observed. Some content, including advertisements may have changed.

Use Ctrl + F to search

0:00

In this episode I speak with world expert

0:02

on deuterium depletion and cancer

0:04

, dr Gabor Schumli , from Hungary

0:07

. He has dedicated his professional

0:09

life to understanding and treating cancer

0:11

with methods that reduce the concentration

0:14

of the heavy hydrogen isotope

0:16

, deuterium , in the body . Now

0:18

deuterium depletion is not some fringe

0:21

or wacky alternative healing modality

0:23

. Rather , it is a thoroughly researched

0:25

scientific topic with decades

0:27

of benchside and clinical evidence

0:29

of efficacy . The benefits are understandable

0:32

when we step out of the

0:34

DNA , rna and nuclear

0:36

genomic view of cancer and into

0:38

a mitochondrial , metabolic and

0:41

bio-energetic model of cancer

0:43

, which I and others believe it

0:45

represents . Dr Schumli has

0:48

had amazing success with this approach

0:50

and has again extensively

0:52

published this in the peer-reviewed literature , as

0:54

well as making it access to people through

0:57

two published books , the most recently titled

0:59

Deuterium Depletion , which was

1:01

published in 2022 . For those

1:03

who are new to the concept of deuterium

1:05

as it relates to biology , please

1:07

check out my earlier episodes with Dr Jalal

1:09

Khan , dr Serapiu and

1:12

Dr Laszlo Boros . I

1:14

hope that you enjoyed this episode and it

1:16

offers you some further understanding

1:18

of the biochemical basis of cancer

1:20

. I particularly hope it can be

1:22

of value to other health practitioners

1:25

, particularly GPs , family

1:27

doctors and oncologists , who have

1:30

a potential role in guiding

1:32

patients through a deuterium depletion

1:34

protocol in addition to standard

1:37

oncological therapies

1:39

. Thank you and enjoy the show

1:41

. Dr

1:49

Gabor Schumli , thank you for coming onto my podcast

1:51

. You're welcome . So let's start

1:53

with this idea of deuterium

1:56

and how it relates to

1:58

cancer . You're

2:00

obviously a world expert on the use of deuterium-depleting

2:04

procedures or

2:06

regimes to assist

2:08

in cancer treatment , and I

2:11

think we could start by explaining to people

2:13

the concept of deuterium

2:15

, because that will give

2:18

us a good background for what we talk

2:20

about later in this discussion .

2:25

I was a teenager when I decided to do

2:28

something with this cancer

2:31

. The first thing I

2:33

declared that I'm not going to

2:35

find a drug , because

2:37

I don't believe that there is any drug which would

2:40

be able to effectively cure

2:42

cancer . My concept was when

2:44

I started thinking about cancer

2:46

, what should be the mechanism

2:48

and how can the cells regulate

2:50

the cell growth ? Because I

2:52

believed if we find a way how

2:55

the cells can regulate the cell growth

2:57

in that way we can find

3:00

a way to cure cancer . And

3:02

I was lucky because Albert

3:05

Sangerdi , who is one of the Hungarian Nobel laureates

3:08

, gave an interview in

3:10

the early 70s and in

3:12

his interview he said

3:14

one word . He said submolecular

3:17

. So he suggested that

3:19

it is not possible

3:22

that the huge protein molecules would be

3:24

responsible for that very precise

3:26

regulatory system

3:28

and he suggested that we should

3:30

go to submolecular level . So

3:33

I kept it in my mind that submolecular

3:35

. And he recommended that electrons

3:37

should be that small particle

3:41

and I kept it in my mind that submolecular

3:44

. One day the idea came to my mind that maybe

3:48

the hydrogen ion , which is a small

3:51

positively charged element

3:54

, should be that submolecular particle

3:56

which has a key role in that

3:59

cellular regulatory system . And

4:01

four years later I

4:04

was a student at the university and the

4:06

other idea came to my mind that

4:08

there is a heavy hydrogen

4:10

, it is called deuterium , and

4:12

that was in 1918 . So I

4:14

was sure that somehow the deuterium

4:17

hydrogen together are responsible

4:19

to regulate the cell growth . I graduated in

4:21

1982 and then I started

4:23

to find a job which on

4:25

a cancer field . But I couldn't find . So

4:29

I continued my DNA work . Later

4:33

I defeated my PhD

4:35

. Then I went to Germany and the United States

4:37

and when I came back from the United States

4:40

I started to find again a job which

4:42

is cancer related . And

4:44

at that time , in 1990

4:47

, I started to work at the Hunger

4:49

and Nations Oncology and

4:51

I started to investigate the possible

4:54

role of the deuterium in the living organism

4:56

. So the question was and

4:59

that was surprising me that everybody

5:01

knows that the deuterium is present in nature

5:03

. The ratio is 6600

5:07

to 1 between

5:09

the hydrogen deuterium . Everybody

5:12

knows that the deuterium behaves

5:14

differently in chemical reaction

5:16

because due to the 100% mass difference

5:19

and even that nobody

5:21

investigated it for 60

5:23

years . But there is any role

5:25

of the deuterium in the living

5:27

organism and I guess the reason

5:30

was that this 6600 to

5:32

1 ratio , the people believe

5:34

that we can ignore it . So

5:36

the question , what I addressed really

5:39

can be ignored at deuterium . And

5:42

it's even

5:44

more surprising that when we talk

5:46

about PPM , so if we take

5:48

1 million hydrogen , we

5:51

can find 150 , 155

5:53

deuterium out of 1 million hydrogen

5:55

. This is the reason that we talk about PPM

5:58

, of the D level , but we

6:00

explain the de-concentration in millimole

6:02

because then somebody go to the doctor

6:05

and got a blood

6:07

report . They will

6:10

find that the calcium level

6:12

is about 2.5 millimole , the

6:14

magnesium concentration or

6:16

about 1 millimole , but

6:19

the deuterium level is 12 millimole . Even

6:21

it is not on the test

6:24

. So the question was can

6:27

we ignore the deuterium if

6:30

the de-concentration is 6 times

6:32

higher than the calcium or 10

6:34

times higher than the magnesium in the blood ? So

6:37

in the very first experiment I used

6:40

deuterium-depleted water . I

6:42

prepared media for cancer

6:44

cell lines and

6:47

I checked the cell growth in

6:49

artificial media with deuterium-depleted

6:52

water and

6:55

the first data was shocking because

6:57

I found that in

6:59

deuterium-depleted media the cancer

7:01

cell growth was slowed down or

7:04

was stopped completely . The

7:07

other series of the experiment we

7:09

transplanted human breast cancer

7:11

to mice and we replaced

7:13

the drinking water with the mice deuterium-depleted

7:16

water and they found that we could

7:18

stop the cell growth and we can get complete

7:20

tumor regression in the mice drinking

7:23

deuterium-depleted water and

7:26

the very first data and results

7:28

was published in 1993

7:31

. In that paper we concluded

7:33

that the nature-occurring

7:37

deuterium is essential to keep

7:39

the normal growth rate in the living organisms

7:42

and the cells and

7:44

we combined

7:46

our data with the data

7:49

of other scientists . Other

7:51

scientists would prove that when

7:53

a growth hormone binds to the membrane and

7:56

that membrane on hydrogen out of the cells

7:58

and pick up on sodium from

8:01

the outer space of the cells

8:03

and that transportation

8:06

, increased transportation of the hydrogen

8:08

caused a pH increase in

8:10

the cell and everybody agreed that

8:12

that increase of

8:14

the pH should be responsible to

8:17

trigger the cell division . So

8:19

in our very first paper we concluded

8:22

that when the

8:24

growth hormone activates and stimulates

8:27

the membrane

8:29

and that sodium-hydrogen antiport

8:31

, that we prefer

8:33

to transport the hydrogen , which

8:36

means that activation

8:38

results a higher deuterium-hydrogen

8:41

ratio and that changing

8:43

the age ratio , a higher deage

8:45

ratio , would be responsible to trigger

8:47

the cell division . So when

8:50

we keep the cells on a deuterium-depleted

8:52

media it should lift up the age

8:54

ratio to the threshold from a lower level

8:56

and that goes to

8:59

difficulties for the cells to do that and

9:02

even we could conclude that somehow

9:05

the cancer cells are very

9:07

sensitive from the lowering

9:10

the concentration and finally

9:12

, that can cause and triggered

9:15

the octosis of the cancer

9:17

cells . So the very

9:19

first paper that the nature occurring deuterium

9:21

, essential for the normal growth

9:23

rate and for the physical processes

9:26

, With the low D level

9:28

we can trigger the

9:31

necrosis of the cancer cells

9:33

and the man is one

9:35

part of the man is how to regulate the cell

9:37

growth . It depends on the deage

9:40

ratio and that the deage

9:42

ratio increase the

9:44

threshold that can trigger the

9:46

cell division . So that was

9:48

the very first part of our study and we published

9:51

, and later we

9:53

continue our research and

9:56

we know that finally

9:59

, our D level is depends on

10:01

one , two thing the

10:03

one , what type of water

10:06

we drink and what type

10:08

of food we eat . Because

10:11

the water , what we drink , it

10:13

is about 1.5 to 2 liter per

10:16

day . That can strongly

10:18

determine the average D

10:20

level of our body . But

10:22

we every day synthesize about 0.3

10:25

, 0.4 liter water

10:28

. This is called metabolic

10:30

water , which is made in the

10:32

mitochondria . And

10:34

when the mitochondria is producing this

10:37

metabolic water , then the hydrogen

10:39

is coming from the lipids , from amino

10:42

acids or from the carbohydrate

10:45

. And so

10:48

, very first step , I went to the shop

10:50

and I bought different type

10:52

of food I mean sugar

10:55

, cottage

10:58

or land

11:00

or fat . I

11:03

brought this type

11:05

of water to the research institute

11:07

and asked them take out the

11:10

water from this food and burn

11:13

that dry food to water , because

11:15

that will be the water of what the mitochondria

11:17

will produce . We

11:20

found that the data showed that when

11:22

the mitochondria burn the carbohydrate

11:24

, that will produce metabolic

11:27

water with 150 ppm deconcentration

11:30

. When the mitochondria

11:32

burn the proteins , that

11:35

will produce about 135-38

11:39

ppm deconcentration

11:41

. But when the mitochondria

11:44

burn the fat , that will produce

11:46

118 ppm

11:48

deconcentration . So

11:52

our day-level

11:54

will depend on what

11:56

is the composition of the diet . The

11:59

more carbohydrate we

12:01

eat to cover

12:03

the calorie intake , the metabolic

12:06

water , the more fat we eat , it

12:09

means we're burning fat

12:12

and producing 118 ppm

12:14

. That means we can

12:16

lower the deconcentration

12:19

of the metabolic water . So

12:21

in our body our average

12:24

deconcentration will

12:26

be the combination of

12:28

the water we drink and the combination

12:31

of the diet we eat . And

12:33

the more fat we eat , the

12:35

lower will be the D-level . That

12:38

way we can regulate and that will determine

12:41

our deconcentration

12:43

. So what we offer

12:45

people now based upon our data , first

12:49

of all , the

12:51

biggest problem for the society

12:53

, that

12:56

the fat is said

12:58

this is a bad food and

13:01

in the last 50-60 years

13:03

it was said that we should

13:05

increase the calorie intake by

13:08

carbohydrate and

13:10

it means that the society in

13:12

the last 50-60 years leaves their

13:14

lives with a deconcentration

13:17

pretty close to the 150 ppm

13:19

, because the

13:21

ratio of the calorie intake of

13:24

the fat is pretty low . So

13:26

what we suggest ? First , change

13:28

the diet just to

13:30

reduce some but the deconcentration

13:33

of the metabolic water and

13:35

or consume due

13:38

to deprecated water . Depending

13:40

on whether you are healthy , whether

13:43

you are diabetic or

13:45

has a metabolic disease , or

13:47

depending if you are a cancer patient

13:50

, you have to consume another type

13:52

of due to deprecated

13:54

water . And if we

13:56

consider what is the

13:58

role of the deconcentration of life

14:00

and if we

14:03

and that

14:05

way we have a chance to

14:07

intervene very effectively into

14:09

that regulatory system , and

14:11

this is the reason that we believe that when

14:14

the due to depletion will be part of

14:16

the oncotherapy , we

14:18

can drastically reduce the

14:20

death caused by cancer

14:22

. And if the due to

14:24

depletion would be part of the treatment

14:26

of the metabolic disease , that will be very

14:28

, very effective and on the healthy

14:31

population , we would be able

14:33

to reduce the incidence of cancer and

14:36

to prevent the

14:38

metabolic diseases . This is how we

14:41

think today .

14:43

There's so much there . That's incredible

14:45

what you've laid out . I

14:47

really wanted to get you on because I think

14:49

that this is such a promising intervention

14:52

that people can use in

14:54

conjunction with their standard therapy and

14:56

there's no reason why it precludes

14:59

the use of existing

15:01

, maybe mainstream , oncology treatments

15:04

. And I want to go back and just recap

15:06

for the listeners , because you

15:09

said a lot there and essentially

15:11

we've got these two different types of hydrogen

15:14

. One is a heavier hydrogen deuterium

15:16

and the ratio of

15:19

deuterium to hydrogen is regulating cell

15:21

growth . So your early work showed

15:23

that when the

15:25

ratio of hydrogen to deuterium

15:27

was higher or there was less

15:29

deuterium , then the cell was

15:31

less likely to replicate

15:34

and therefore you were able to induce

15:36

programmed cell death or apoptosis in

15:38

these cancer cells . So I

15:41

think that's a key point for people to

15:43

realize or internalize

15:45

, which is that cancer

15:47

is this mitochondrial metabolic

15:49

problem and , contrary

15:53

to a lot of the messaging that we get in the mainstream

15:55

about cancer being a genetic

15:58

problem , the problem is really in

16:00

the mitochondria . So by

16:02

regulating and adjusting

16:04

the ratio of deuterium to hydrogen , we

16:07

can influence the cancerous

16:09

cell to replicate . So based

16:12

on that , you proposed this

16:14

idea of regulating our total

16:17

body deuterium using food and water

16:19

. I want

16:21

to ask you a couple of questions about

16:24

the food before

16:26

we go into the water , and you said specifically

16:28

that the fat , when you burn

16:30

it in the mitochondria , makes the most

16:33

amount of deuterium-depleted metabolic water

16:35

, and I believe , in agreeance

16:37

with you , that the anti-fat

16:39

narrative from Ansel Keys over

16:41

the past 60 years has been incredibly

16:44

harmful and obviously the demonization

16:47

of that , and for a number of reasons , but this is

16:49

just another one of it . My

16:51

question is specifically

16:53

with regard to refined

16:57

oils , or seed oils as

16:59

they're commonly known . Do you

17:01

what has been your experience and your testing

17:04

of the deuterium content of these

17:06

industrially refined oils

17:08

?

17:10

Yeah , so it's . There

17:14

is a paper published that Richard

17:17

Robbins were able

17:19

to measure the de-concentration

17:22

of the fatty

17:25

acid chain and

17:28

he could prove that the

17:30

D-level in

17:32

a linoleic acid on

17:34

the carbon 9 , the de-concentration

17:37

is 60 ppm and this is true

17:39

for the carbon 13, . Which

17:42

means that the metabolism is

17:45

so dedicated and so precise

17:47

that when the cell

17:50

is producing , synthesizing

17:52

a fatty acid

17:54

, they can specifically

17:57

modify the

18:00

D-level depending on the

18:02

number of the carbon . So it

18:04

is not just randomly distributed

18:07

in the cell , even in a given

18:09

molecules . So we

18:12

never investigated changing

18:15

or investigating different type of

18:17

oil and different type of long

18:20

chain fatty , depending

18:22

maybe on the source , depending

18:25

on the plant which is synthesizing a given

18:27

product , can modify

18:29

the distribution and the concentration

18:32

of the deuterium on a given molecules . For

18:35

example , which is very clear , with the carbohydrate

18:38

, the plant has

18:41

three systems , three chemical

18:43

way to fix the carbon dioxide

18:45

from the air . It is called

18:47

the C3 , c4

18:50

and CAM . And

18:52

even the plants , which

18:54

is a weed , for example , belongs to the

18:56

C3 way to

18:58

fix the carbon dioxide . They produce

19:01

a more depleted carbohydrate

19:03

than the other plants which , for example , the

19:06

corn , which use the

19:08

metabolic pathway according

19:10

to C4 . And the pineapple

19:13

can enrich the deuterium

19:15

in the plant . So that

19:17

shows that depending

19:20

on the plant , depending on a given

19:22

biochemical pathway , can

19:25

be even the same type of

19:27

biochemical pathway

19:29

can be different depending on

19:31

the plant , the cell and so on

19:33

. So it's an extremely complex

19:35

system and it requires lots

19:38

of science and lots of research

19:40

to figure out what's going on . When

19:43

we check the oil , the oil

19:45

deuterium level wasn't

19:47

so depleted than the

19:49

fat . So if we check

19:52

the different type of foods , the

19:54

lowest de-level is in the fat . But

19:57

for example the capsaicin which

20:00

makes the pepper very hot , it's

20:03

the concentration , only 60

20:05

ppm . Because

20:07

what we see , that in each

20:09

chemical reaction always

20:11

the hydrogen will be preferred

20:13

, because there is a tenfold difference

20:15

in the speed the

20:18

chemical reaction is running with hydrogen or deuterium . So

20:22

the more complex a molecule

20:24

we can consider , the more depleted

20:26

for deuterium . Because

20:28

during the synthesis , always

20:31

the chemical

20:33

reaction , we go faster with the hydrogen . So

20:36

that way we can differentiate

20:38

and we can consider that one molecule should

20:41

de-level , we'll be closer to 150

20:43

ppm , the other maybe

20:45

will be much lower than 150

20:49

ppm .

20:49

It makes so much sense to me , which is

20:52

that if you're eating foods

20:54

of animal origin , then

20:56

Mother Nature has kind of already created

20:59

its deuterium depleted food

21:01

source , whereas if you're eating a plant

21:04

, then you're

21:06

not benefiting from this natural process of

21:08

eating fats that

21:10

have already been deuterium depleted

21:13

. The question

21:15

, I guess , was relevant , and it's interesting that

21:18

the seed oils do have more deuterium

21:20

in them than animal fat , and I think

21:22

that is one reason why

21:24

they're such an undesirable

21:27

food for most

21:29

people , and the fact that most people have replaced

21:31

saturated fat with the seed oils

21:34

is very problematic . So

21:37

let's talk about water , and

21:39

it makes sense to me that the mitochondria

21:41

need to be burning food that is the least

21:44

deuterium content in order to produce the most

21:46

deuterium depleted water . But in

21:48

terms of drinking water

21:50

that is , having a

21:52

low deuterium concentration , can

21:55

you talk to the natural

21:57

prevalence of or concentration of deuterium

21:59

in various waters that

22:02

you might find naturally ?

22:05

So you are living

22:07

in Australia , you are

22:09

very close to the equatorial

22:12

area , so the ocean

22:15

level is 155 ppm

22:17

. And when the clouds appear

22:20

and moving to the south

22:22

and north poles easier

22:25

or easier can lose the

22:27

heavy water molecules

22:29

. It means that the rainwater

22:32

D level is decreasing . At

22:34

the farther from the equatorial

22:36

area the lower the de-concentration

22:39

of the rainwater . And

22:41

this is true when we go uphill

22:44

. The higher the altitude

22:46

on the hillside , the lower the D level

22:48

. And this is also true the farther

22:50

from the ocean , the lower the

22:53

D level . So it means in Hungary

22:55

, in central Europe

22:58

, we have about 148

23:00

ppm de-concentration

23:02

. If you go to Edmonton

23:05

in Canada , far from the ocean

23:07

and pretty north , it should be about 100 certified

23:10

ppm de-concentration

23:12

. In the middle of Africa it should be

23:14

about 155 ppm because

23:16

they've got back the same water which

23:18

is evaporated from the ocean

23:20

and that will determine

23:23

the D level of the plants

23:25

which is cultivated on a given

23:27

area and also modified

23:30

by the biochemical processes of

23:32

the plant , so that again

23:35

which can strongly modify

23:37

the D level . But it is very important to say

23:39

because you mentioned that . So we

23:41

concluded that the lower D level

23:43

can stop or can slow down

23:45

the cell growth . But when we

23:47

talk about the application of

23:49

D-tim-de-pre-tid water we

23:52

do not have to worry about that

23:55

. We'll reduce

23:57

the growth of the healthy cells Because

24:00

what we found , that the

24:03

healthy cells because

24:05

they are healthy cells and the metabolites is

24:07

perfectly working well

24:10

. They , day by day

24:12

, are able to adapt the metabolites

24:14

to the lowering D level . And

24:16

the big difference between the cancer cells

24:19

and healthy cells , that

24:21

the cancer cells has

24:23

an impaired mitochondria

24:25

. And this is the reason

24:28

that because the

24:31

mitochondria is not able to produce D-tim-de-pre-tid

24:34

metabolic water , so when

24:36

the growths form , bind to the membrane and stimulate

24:38

very easily can lift up the

24:40

D-age ratio to the threshold to trigger

24:42

the cell division . When

24:48

we modified the D level of the cancer

24:51

cells day by day , consuming the patients

24:53

due to in depleted water

24:56

, it's a challenge day by day and

24:58

that can trigger the radicals and

25:00

that radicals finally can trigger

25:02

the apoptosis

25:04

and this is how it works . So

25:07

for healthy population we

25:10

suggest to consume due to in depleted

25:12

water with 125 ppm

25:15

or 105 ppm . We

25:18

have run a phase two clinical study

25:20

with patients

25:23

having metabolic disease . They

25:26

consumed 105 ppm

25:28

, 1.5 litre per

25:30

day for 90 days and

25:33

when we checked the D level of the blood from

25:36

148 , we reduced

25:38

to 133 ppm . So

25:41

that clearly shows that consuming

25:43

DW we reduced the deconcentration

25:46

of the body and that way

25:48

in that clinical trial

25:50

we could reduce the fasting

25:53

glucose level and then

25:55

we could reduce the insulin resistance

25:57

. That way we could increase

26:00

the HDR cholesterol

26:02

, the so-called good cholesterol concentration

26:05

, and the blood count

26:07

didn't change , so we did not

26:09

cause any trouble or

26:11

drop of the blood counts or whatever

26:13

. So this is what we offer

26:15

to have CPP to

26:18

bring the D level to

26:21

the range of 125

26:23

, 450

26:25

ppm , because in that

26:27

range the mitochondria works much

26:30

properly and the insulin

26:32

signal system is also

26:34

working much properly . The

26:36

basis that I says that we

26:39

have run a three

26:41

red study . In the

26:43

red study we made the reds

26:45

diabetic and we checked whether

26:48

we can reduce the blood sugar

26:50

level of the reds . The

26:52

point was when the reds did

26:55

not receive insulin the D

26:57

level did not modify the blood sugar

26:59

level . It was pretty high in that

27:01

red . But when

27:03

the reds received 25

27:06

ppm and got insulin

27:09

, that significantly reduced

27:11

the blood sugar level of the

27:13

diabetic reds . But

27:16

in then we repeated the

27:18

experiment . If we checked not only

27:20

25 ppm but 1

27:22

, 25 and 75

27:26

, 105 . And the point was

27:28

that not the lowest D concentration

27:31

reduced the best rate of 25

27:33

ppm . And in the third

27:35

experiment we checked between 125

27:37

and 150 ppm , changing

27:39

by 5 ppm , and that

27:41

clearly showed that the

27:44

best was the 125 ppm

27:47

. And we also checked

27:49

I

27:51

don't know whether the people do

27:54

not know , I guess what the meaning of

27:56

glutathor protease is staying in

27:58

the cytosol and

28:00

when the insulin bind to the membrane and

28:03

trigger the signal system , that

28:05

will stimulate the glutathor to move to

28:07

the membrane because that glutathor will

28:09

pick up the glucose from the blood vessel . So

28:12

in that red study we checked whether

28:14

the D concentration

28:17

can modify

28:19

the glutathor concentration

28:21

in the membrane of

28:23

the red muscle and

28:25

we found that the highest glutathor

28:28

concentration was at the 125

28:30

ppm , which means that the insulin

28:32

signal system work much

28:34

properly at the 125

28:37

ppm . So this is , and after

28:39

that we checked with a human clinical study

28:41

and that was the same . We found

28:43

that when we reduce that D

28:47

level of these patients with metabolic

28:49

disease , that way we can improve

28:51

their metabolism , reduce the blood

28:53

sugar level and all these things . So

28:55

this is how it works .

28:57

Fascinating , and I'm very much

28:59

interested in metabolic disease as

29:02

well , and I really think that they're just two sides

29:04

of the same coin . When it comes to

29:06

mitochondrial dysfunction , and

29:09

whatever you have the misfortune

29:11

of manifesting with regard to mitochondrial

29:13

disease will determine whether that is

29:15

diabetes or some form

29:17

of cancer . And

29:20

125 ppm

29:23

I'll keep that in my head and I

29:25

want to talk to you about protocols . But

29:27

just before we do that , what

29:29

about the natural deuterium

29:32

depleting mechanisms of the body ? Because

29:34

if you've mentioned that the

29:37

deuterium content of our

29:39

bodies is influenced by , obviously , what

29:41

we eat and what we drink , what about our

29:43

natural ability to get

29:46

rid of deuterium ? And the reason I ask is

29:48

because there might be native

29:51

populations living at the equatorial latitude

29:53

whose water is 155

29:57

ppm of deuterium . They

29:59

eating pineapples

30:01

or bananas , mangoes

30:03

, yet they have low

30:05

incidence

30:08

of metabolic disease , mitochondrial

30:10

dysfunction and cancers , and I'm thinking

30:13

of , perhaps , maybe , populations like the Katarvins

30:15

in Melanesia . So

30:18

what mechanisms have

30:21

we evolved specifically in people who are

30:23

living equatorially or living in their natural

30:25

environment .

30:25

I understand the question and I guess this is

30:27

a very good question and important . So

30:30

I don't believe that

30:33

each population is

30:36

adapted to the de-concentration

30:38

where they live and

30:44

I have seen several podcasts

30:47

with other people . So I

30:50

don't believe that the aim

30:52

is to reduce

30:55

the de-level as much as possible

30:57

and I do not agree that the

30:59

lower the de-level the better . I

31:02

think the deuterium-hydrogen ratio

31:04

is crucial and

31:07

the question is where is

31:09

the optimal deuterium-hydrogen

31:12

ratio ? As I mentioned at

31:14

the beginning the

31:16

problem of the society that

31:18

we increased with 15 ppm

31:20

the average de-level just because

31:23

we changed the diet . But

31:25

if we can move it back to

31:28

the 125 ppm , 140

31:30

ppm , then that

31:32

would be a big step forward to

31:35

reduce the incidence of metabolic

31:37

disease and cancer In

31:40

our body . When we talk

31:42

about how can leave our body

31:44

, that belongs to , I

31:46

guess , the proteins

31:50

and the

31:52

NH2 groups

31:55

of the amino acids , Because

31:57

in a biochemical reactions

32:00

the amino groups

32:02

are collecting the deuterium

32:04

and that way we

32:06

can eliminate from the body the

32:09

de-level and the deuterium

32:11

. And I also heard

32:13

someone said that maybe the microbiome

32:17

also can be responsible

32:20

, modifying the

32:22

deuterium-hydrogen ratio and removing

32:25

it . I have read

32:27

papers that different microbes

32:30

has a very big

32:32

discrimination between deuterium-hydrogen

32:35

ratio and that way again can

32:38

modify this DH ratio . So

32:40

all these things , finally , will provide

32:43

us a given de-level altogether

32:46

. But so what

32:48

? I would like to say that the

32:51

deuterium is essential . The

32:53

deuterium-hydrogen ratio is

32:56

the way that when the cell

32:58

can modify it , because they

33:00

are deactivating the sodium-hydrogen

33:02

or because they properly

33:05

work in mitochondria and

33:07

changing the DH ratio , that way the

33:10

cells are able to send a message

33:12

to all the molecules in the cell because

33:15

in the exchangeable position always

33:17

will be an equilibrium . So

33:19

if there is an increase in the DH

33:22

ratio because the activation of sodium-hydrogen

33:24

, that will send the message to

33:26

all the molecules and that

33:29

means simultaneously

33:31

the cells can regulate the

33:33

gene expression , protein activity . Let

33:36

me tell you another experiment , what we have published

33:38

. So we know that

33:40

the small

33:42

pharma , big pharma , is targeting

33:45

a gene which was identified

33:47

to have a key

33:50

role in the cancer

33:52

development . So

33:54

we know one of the first gene was the

33:56

tisening kinase , and

33:59

so my question was whether

34:01

we can modify the gene expression , just

34:03

changing the de-concentration of the cell

34:05

. So we kept

34:08

the cells in a deuterium-depleted

34:10

media , in normal media

34:13

and deuterium-androgen media , 300

34:15

ppm , and

34:17

we were able to check

34:19

the expression of over

34:21

700 genes . Over

34:23

200 was kinase gene and over

34:26

200 was cancer-related genes

34:28

. So it is called

34:30

a nanostring technology , which

34:32

means we were able to count one

34:34

by one the copy number

34:37

of a given gene . So how many

34:39

copies was made in different

34:41

de-concentration of the cell

34:43

? And what we found ? That not

34:48

the lower de-concentration

34:50

was a key but the higher

34:52

the level was because

34:55

99% of the cells responded

34:57

to the higher de-concentration . So

35:00

when we use the deuterium-depleted

35:03

water , one

35:05

way we triggered the apoptosis because the

35:09

radicose . But

35:11

that way we simultaneously inhibit hundreds

35:13

of genes having role in the cell

35:15

division , not

35:17

just one gene , one of

35:19

the target of cancer drug

35:21

. So when we talk about

35:24

that , the cells can modify the de-age

35:26

ratio . The key message

35:28

is that no-transcript

35:30

. That way the

35:32

cell are organized and

35:35

harmonized the 2000

35:37

bicochemical processes and

35:39

the expression of thousands of genes . And

35:42

this is how it works ?

35:43

Yeah , and it makes sense to me that

35:45

the deuterium level we

35:47

adapted to a deuterium level of our environment

35:50

and I guess I would ask is

35:52

that a function of mitochondrial

35:54

haplotype and we should be eating the diet

35:56

from which our mother's lineage

35:59

has come from ? That , to me , makes the most

36:01

sense with regard to what our adapted

36:04

deuterium level is .

36:06

So when we start to consume

36:08

deuterium-depleted water , that

36:10

is challenging . We

36:12

typically say that we need about three

36:15

to four months to see the

36:17

efficacy of the deuterium depletion

36:20

, for example in cancer patients , Because

36:22

slowly there is a

36:24

decrease in the can modify

36:27

the expression of genes , the activity

36:30

of different enzymes and

36:32

the healthy cells can do that . But

36:34

challenging , challenging day by day the

36:36

cancer cells , hopefully we can trigger the

36:39

apoptosis and when

36:41

we reach the equilibrium then

36:44

all the metabolites will be adapted

36:46

to a lower de-concentration . So

36:49

when we talk about healthy people , that should

36:51

be between the 100 , 25

36:54

, 140 ppm . But

36:56

when we talk about cancer patients

36:58

, we reduce

37:01

and change the D level every

37:03

two , three months , Because then we

37:05

reach the equilibrium . Then

37:07

the cancer cells which survive

37:10

that part of the reduction

37:13

in D level , they will

37:15

be adapted to that level

37:17

and slowly they can grow again

37:19

. So when

37:21

we talk about cancer patients , we have to

37:23

gradually and

37:25

on a long period of time reducing

37:28

the level . That is the way how we can

37:30

eliminate , hopefully , all

37:32

the cancer cells from the body

37:34

.

37:35

Okay , good , because that's what I wanted to talk

37:37

about next , which is protocols and

37:39

practical implementation . Because

37:41

, like I mentioned to you

37:44

earlier , before we started recording , I

37:46

see in my clinic and

37:48

all across Australia

37:50

there are people that have cancer diagnoses and they

37:52

want to know what more they can do

37:55

to increase their chances

37:57

of a better outcome

37:59

. So the question I

38:01

have is , that is a protocol

38:04

of deuterium depletion in active

38:06

cancer . Is that something a patient can

38:09

do themselves ? Is that something

38:11

that requires close

38:13

supervision , or

38:16

how would you see the most safe

38:18

and effective way

38:21

of doing a deuterium depletion strategy

38:23

for cancer ?

38:25

This is a tough question

38:27

because our aim is and our company working

38:29

on to register deuterium depletion

38:32

water as a cancer drug . So

38:34

we have the facility to produce

38:36

deuterium depletion water in accordance to the GMP

38:39

rules and we are waiting for investors

38:41

to finance the clinical

38:44

study . So right now we cannot

38:46

say that the deuterium depletion is part of

38:48

the oncotherapy . But

38:51

my duty , I guess , and my job to

38:53

bring it to the point when all the

38:55

oncologists worldwide will

38:57

think about how to integrate deuterium

38:59

depletion to the existing therapy

39:01

. And of course I

39:03

keep working on it for over

39:06

30 years and it's

39:08

very difficult to share all

39:10

the knowledge . But this is the reason I wrote a book

39:12

. So in the deuterium depletion

39:14

this is the title

39:16

of the book I wrote

39:18

down the protocols . What

39:21

would be the best way to integrate

39:23

deuterium depletion to radiotherapy

39:25

, to surgery , to hormone therapy

39:28

, targeted therapy , immunotherapy , whatever

39:30

? Because I don't believe

39:32

that we have to replace the existing therapy

39:34

. We have to support

39:37

the therapy with deuterium depletion

39:40

and that would be the way to

39:42

win in that war which is called cancer

39:45

war . So we

39:48

have . Of course , I guess I'm

39:50

the only person who have experienced with

39:52

thousands of cancer patients . I

39:55

have been talking for over 30

39:57

years and in that book I try

39:59

to summarize the knowledge that

40:01

I collected . So there

40:04

are a couple of rules . If somebody is diagnosed

40:09

with cancer , follow the protocols

40:12

, what the oncologist says . I

40:15

never intervene and do

40:18

nothing about to replace it with deuterium

40:20

depletion water . So

40:22

the protocol should be one

40:25

example . They diagnose

40:27

the tumor and they decide to operate

40:30

. If the patients had a

40:32

couple of weeks , two , three weeks before operation

40:34

and start to consume DW

40:37

, that way we can increase the operability

40:39

of the tumor , it will be much easier

40:41

to remove . That could

40:43

be critical in a rectum tumor

40:46

, for example , whether they can

40:48

save the illness or no . And there

40:50

are other parts or other

40:52

types of cancer when

40:55

very important whether we can get

40:57

a shrinkage of the tumor and

40:59

the operation would be much better . The

41:02

other option is the

41:05

radiotherapy . What we see that and

41:07

we know that the radiotherapy

41:10

cause and trigger

41:12

radicals in the tumor and this

41:14

is the reason that the radiotherapy is so

41:17

good and so effective . So

41:19

we see very strong synergistic

41:21

effect when the radiotherapy

41:23

is combined with the deuterium

41:26

depletion . We just recently

41:29

published a paper with 55

41:32

glioblastoma patients

41:34

and within that 55

41:37

patients there were 37

41:39

. And they were lucky to

41:42

combine in DW with radiotherapy

41:44

and the medial survivor

41:46

time was three times longer than

41:48

those who just

41:50

received in the conventional therapy because it

41:52

was 47 months . So

41:55

showing that how good

41:57

combination can be the

41:59

radiotherapy with DW . And

42:02

then we can talk about hormone therapy

42:04

, for example with prostate cancer

42:07

. In

42:09

that case , somebody

42:12

diagnosed with prostate cancer , they

42:15

received the . If it's not operable

42:17

, they received the hormone therapy . After

42:19

two , three years became hormone

42:22

resistant . Then the patient received

42:24

some other and then they cannot control

42:26

it . What we suggest if the

42:28

hormone therapy is

42:31

effective , the tumor marker

42:34

values go down . Then

42:36

we recommend stop the hormone , start

42:39

to consume DW and we

42:41

keep them the tumor marker

42:43

in a low level and maybe

42:45

after half a year they

42:48

can check the PSA . It is still low

42:50

. Stop the DW and

42:52

do nothing . When they see

42:54

that there is an increase in the tumor marker

42:57

, start again with DW and

42:59

then we are not able to keep the

43:01

PS in a low level , then come back

43:04

with the hormone therapy and after

43:06

three zero six months they

43:08

can stop again the hormone therapy . We have paper

43:10

, we published paper that we

43:13

kept control for over 10

43:16

years and the patients haven't

43:19

received hormone therapy because the

43:21

DW could keep the PSA

43:23

on a low level and we

43:26

always say that combining with

43:28

the targeted therapy , the DW

43:31

again can be a very

43:33

good combination . For

43:36

example , the Herceptin . It's

43:40

a good drug to treat breast

43:42

cancer and that

43:45

would be the combination

43:47

, whether it's metabolic disease or

43:49

genetic disease the cancer because there

43:51

is connection , there

43:53

is a gene amplification

43:56

of the EGFR

43:58

, epidermal

44:01

Gross Factor receptor and

44:03

there are much more receptor on

44:05

the surface of the cell . It

44:08

means when the growth hormone binds to the membrane

44:11

and there are more receptor much

44:14

easier and faster can

44:16

stimulate the sodium hydrogen transport

44:18

system , which means much faster

44:20

can generate a higher DHS

44:22

ratio . So when we combine

44:26

the Ddela Bue with , for example

44:28

, with Herceptin , which inhibit

44:31

the binding between

44:33

the growth hormone to

44:35

the receptor and inhibit

44:39

the increase of the DHS ratio

44:41

, that again became

44:45

very , very effective to treat the

44:47

breast cancer patients with that type

44:49

of targeted drug . That is

44:52

true for tyrosine kinase inhibitors

44:54

. So that would be

44:56

the way . I hope in the foreseeable

44:59

future that the oncologist

45:01

can combine it and can integrate due

45:04

to indibition to the existing therapy .

45:06

Yeah , and I want to echo that statement

45:09

, which is that no one's suggesting that they

45:11

do discontinue , or patients discontinue

45:13

their existing therapy . This is

45:15

an adjunct , an addition

45:17

to what is also going

45:20

on from a conventional treatment point

45:22

of view , and to me it makes so much

45:24

sense that we can layer

45:26

on top of each other different protocols

45:29

that target the mitochondria and

45:31

support mitochondrial function . And

45:34

obviously in my previous podcast my listeners

45:36

will know that I've talked to Thomas

45:38

Seeger , who has advocated

45:40

for cold therapy . There's established

45:42

evidence for fasting and if we're

45:44

adding things like ketogenic diet and

45:47

deuterium depletion on top of all

45:49

these other protocols , then

45:51

that makes sense that we're

45:53

basically doing our best to support mitochondrial

45:56

function and therefore improving

46:00

the outcome . I

46:03

want to ask you again

46:05

about a bit more about the exact

46:08

approach , because

46:11

obviously people are going to be reading your book . Not everyone

46:13

can work with you . Specifically , do

46:15

people need to get

46:17

a serum deuterium level tested

46:20

before embarking on deuterium depletion , or

46:23

will some people simply just commence drinking

46:27

deuterium depleted water , as per

46:29

your protocol ?

46:32

We are just working on a paper to publish

46:34

that following . So we already

46:36

have measured the

46:38

D level of the blood and

46:40

another study

46:44

we followed how the deuterium level is changing

46:46

. So I don't believe that the

46:50

measuring of D level is a key issue

46:52

. The key issue is to consume deuterium depleted

46:54

water . But of course when

46:56

we start a clinical study we

46:59

will take the samples and measure it and

47:01

find the correlation how

47:03

fast we have to reduce the D

47:05

level , how long we have to keep

47:08

it on a low level , the D level . That

47:10

again takes time , takes

47:12

money and takes big

47:15

effort to figure out all the details

47:17

of this . What we can state

47:20

that consuming DDW

47:22

will reduce the D level and

47:25

there is a strong correlation that the lower

47:27

the de-concentration of the DDW

47:29

, the lower will be the knee

47:32

level of

47:34

the patient's de-concentration . Typically

47:38

we can say that within

47:41

two , three months there is equilibrium

47:43

with a given de-concentration . So

47:45

if we want to keep a

47:47

gradual decrease of D level we

47:50

have to change the D level intake

47:52

of the de-concentration . And it

47:54

is another question , depending

47:57

on two more types how

47:59

fast and how frequently

48:02

we change the D level of the

48:04

consuming DDW . And

48:07

it should be hundred different

48:09

times depending on staging and the conventional

48:12

therapy and all these things . But

48:14

the basic rule is that two , three months change

48:16

the D level . This is what we

48:19

say . To

48:21

measure the D-level can be important

48:24

when we talk about

48:26

whether that water is

48:29

real due to depletion , because

48:31

unfortunately it is very easy

48:33

to sell fake products

48:36

which is said due to depletion

48:38

. So sometimes

48:41

we receive samples from

48:43

patients and water samples

48:46

and that way we can measure it and

48:48

we send back what is the D-level

48:51

. We typically use precipitated

48:55

exhaled brass water which

48:57

reflects the de-concentration

49:00

of the body . So if

49:02

those who are wondering

49:05

whether the D-level is a

49:08

given , which is said about a given

49:10

water , this is a way to

49:12

either sending the water samples

49:14

or checking the

49:18

D-level of the exhaled brass

49:21

, precipitated brass

49:23

water .

49:25

Okay and say someone

49:27

embarks upon a deuterium-depleting

49:30

protocol for , say , they've

49:32

got active cancer , what are the potential

49:34

side effects or adverse effects

49:36

from

49:38

doing this ? Is there a tumour-licence that

49:40

they might have to deal with , or is

49:42

this a well-tolerated procedure on

49:45

the part ? Does it depend on the tumour type ? Let

49:48

us know about that .

49:51

So if someone starts to consume DW

49:53

, of course , depending on the size

49:56

of the tumour , the sensitivity of the tumour , they

49:59

not feel better because

50:01

when the tumour

50:03

starts to necrotize , this

50:06

is what the people can feel Tumour can

50:08

be warmer . The size

50:10

of the tumour temporary can be bigger

50:12

because we initiate

50:14

an inflammatory reaction . Even

50:19

we recommend not to go to CT or

50:21

MRI after starting

50:23

to consume DW because

50:26

in the first two , three months that

50:28

maybe you show

50:31

the bigger tumour size but that means

50:33

that there are more cancer cells . But

50:35

that is an inflammatory reaction

50:37

, that the tumour is getting bigger , that

50:39

the immune system is

50:42

going to remove the dead

50:44

cells . So lung cancer

50:46

patients starting coughing

50:49

out the tumour , the necrotize

50:51

tumour irritate the lung and

50:53

coughing out the tumour , the

50:56

colon cancer some stuff

50:59

can be removed by the faces

51:01

, can be some slight

51:04

blood in the

51:06

faces . So these are

51:08

always related to the healing process

51:11

and when we check

51:13

the blood counts of these people we

51:15

never see that we drop the blood

51:17

cell number or white blood

51:19

cell number . So we do not

51:21

reduce

51:24

the immune system activity or these

51:26

things . So this is not a so-called

51:29

chemotherapy type of

51:31

intervention . When we

51:33

are suggesting people consuming

51:35

DW , the

51:38

people feel

51:41

it more . Gain

51:43

vein , sometimes

51:45

the bone metastasis . The

51:47

pain is getting stronger

51:49

at the beginning than they can feel

51:52

the relief that

51:54

no strong pain in

51:56

the bone . So the point is

51:58

that starting to consume DW

52:01

, do not hope

52:04

that next day you feel better . No

52:06

, it takes two , three months that we can

52:09

conclude . Okay , that was the

52:11

beginning and now we are here and

52:13

to prove it with CT , mri

52:16

or other objective

52:18

numbers which prove the improvement

52:21

of the patient .

52:22

Yeah , and I want to echo

52:25

the point you made , which is that this isn't

52:27

an immunosuppressing therapy and

52:32

, contrary to what

52:34

chemotherapeutic agents are doing , or immunosuppressive

52:36

agents , this is not going

52:39

to be dampening down or

52:41

suppressing the immune system . So

52:43

I guess that is important

52:46

, because every intervention

52:48

that we prescribe in medicine well

52:51

, every medication that we prescribe in medicine has adverse

52:53

effects . But simply

52:55

deuterium , depleting

52:58

the water to

53:00

what you're

53:02

advocating for isn't

53:04

, as you mentioned , having an adverse

53:06

effect on healthy cells

53:08

. So I think that's a very

53:10

important point . So my

53:13

question is how to scale

53:15

this kind of oncological treatment

53:18

or give more patients access to

53:20

this , because it

53:23

sounds like it's quite a specialized process

53:27

that you need to follow up with someone . Or

53:29

have you found that people are managing

53:32

themselves on

53:34

just reading your book ? Or how

53:37

is the average person going with

53:39

deuterium depletion for cancer ?

53:42

I guess most of the average people

53:44

somehow got some information

53:47

about DW . They can get it

53:49

one way or other and

53:51

they start to consume . Followed over

53:53

2000 cancer patients . They

53:56

regularly came back to us , shared

53:58

the data and we

54:00

were chatting about

54:03

his or her stages . But

54:06

99% of the patients

54:08

just start to consume and

54:11

do it one

54:14

way or other . We are very

54:16

happy if someone starts

54:18

to learn something first about the

54:20

deuterium depletion , because

54:22

sometimes it's happened with our partners

54:26

that they started to consume

54:29

and after a couple of months come and

54:31

asking and maybe they did

54:33

not use the right D level , they

54:36

did not change the D level on the right time

54:38

or they did not integrate

54:40

it on the best way deuterium depletion

54:43

to the therapy . So

54:46

I guess that

54:48

should require a long time

54:50

to educate the

54:53

oncology society and to educate

54:55

the cancer

54:57

population and the healthy population and

55:01

I hope we can proceed

55:03

in that way . But the critical

55:05

step is the clinical study and

55:08

the approval from the authority

55:10

. So the rule says we

55:13

cannot claim . But this is

55:16

the way we are working on to register

55:19

DW as a drug , because

55:21

that will help us to communicate

55:23

directly and this is the only

55:25

way that we can take part

55:28

of the oncotherapy , the DW

55:30

.

55:31

Yeah , it's interesting and

55:33

important question because there's

55:36

so many potential doctors

55:38

who could assist their patients with

55:40

a deuterium depletion protocol

55:43

, given the safety and given the fact

55:45

that this isn't an immunosuppressing drug

55:47

, and to simply

55:49

guide people through this . With the

55:52

explosion in cancer diagnoses , I

55:54

think people need as many tools as possible . So

55:57

it just seems like a big challenge in my mind

55:59

is to provide enough education

56:02

to doctors and maybe

56:04

oncologist , family medicine

56:06

doctors , to be

56:08

able to have enough training to guide patients

56:10

through this protocol , so that patients

56:12

aren't simply on their own

56:14

doing a treatment

56:17

protocol by themselves without supervision

56:19

.

56:21

I guess they are waiting for the approval

56:23

from the authority . So the

56:25

step one to get the approval

56:27

from the authority , fda , ema and

56:30

then should be part

56:32

of the oncotherapy . Without that we

56:35

cannot proceed . Yeah

56:38

unfortunately .

56:40

And do you train ? Does your organization train

56:42

doctors or are there courses ?

56:43

that no , there's no , no

56:46

, no .

56:48

Yeah , okay , yeah , no , sir , because I'm

56:50

just . I'm just thinking about how we can give

56:53

wider access to people and but

56:56

, like you said , we do need more

56:58

, I guess robust studies to

57:01

satisfy the

57:03

regulatory bodies . But

57:06

from from the

57:08

30 years and the two more than 2000

57:10

patients that you've dealt with , sounds like this

57:13

is unequivocally a safe

57:15

intervention and effective .

57:18

So we were lucky to close

57:20

a phase two double my chemical trial with

57:22

prostate cancer and in

57:24

that study we could prove the efficacy of DW

57:27

. But the authority did not accept it and

57:30

then we just so

57:32

that was a so called prospective study . But

57:34

what we have done , we publish

57:36

data with a so called retrospective study

57:39

. So we collected over

57:41

200 breast cancer patients and

57:43

we published the data . Then we

57:45

published the glioblastoma

57:48

55 patients . We published

57:50

almost 200 lung cancer patients

57:52

. So in that case we

57:54

very precisely could choose and

57:58

make the subgroups depending

58:00

on the staging type of the lung

58:03

cancer , type of the therapy

58:05

. And we could prove that the

58:07

median survival time was

58:10

increased with three to seven for

58:13

the increase , which is

58:15

extremely clear evidence

58:17

that the due to depression how

58:19

effective can be . But maybe the

58:21

the best way and the fastest

58:23

way to to reduce the

58:25

death goes by cancer If

58:28

the DW would be

58:30

part of the therapy when

58:32

somebody is in a remission . So

58:35

luckily lots of cancer

58:37

patients became two more free because

58:39

surgery , radiotherapy

58:42

and all the other therapy . But

58:44

the bad news is they go back

58:46

every half a year and every

58:48

year and worrying what

58:50

the control will show and

58:53

they cannot do anything because

58:55

the therapy was completed

58:57

and waiting whether there is a

58:59

recurrence of cancer or not . So

59:01

we again published a paper

59:04

that 204

59:06

cancer patients consuming

59:08

DW was followed over a thousand

59:10

years . So that was the cumulative

59:13

follow up time and

59:15

we lost 13 people out

59:18

of 204 . Two

59:20

of them died not because of cancer and

59:23

a half of them died those

59:25

who consume DW . They

59:29

never came back and

59:31

the average time was they died 4.1

59:33

years later . Those who

59:35

regularly came back consume

59:38

DW for three , four months every

59:40

year . They never relapsed . Be patient

59:42

, the treatment

59:45

has been completed . They

59:48

are tumor-free . They

59:50

would follow that therapy Drinking

59:53

DW . We recommend tumors 105

59:55

, tumors 85 ppm . This is what I wrote

59:58

in my book and

1:00:00

they repeat it every year in the next four

1:00:02

, five , six , seven years . That

1:00:04

way we should prevent the relapse

1:00:07

. So that would be my

1:00:09

message to all the people who are tumor-free

1:00:12

now and to prevent them not

1:00:14

be cancer patients again .

1:00:17

Yeah , yeah , very interesting

1:00:20

. The question I have

1:00:22

next is regarding the metabolic

1:00:24

syndrome and metabolic diseases

1:00:26

, and you mentioned

1:00:28

earlier that 125 ppm is

1:00:30

the kind of target of the total body deuterium

1:00:33

to ppm

1:00:35

to resolve metabolic disease

1:00:38

. And is this a much less

1:00:40

hands-on process than cancer

1:00:42

for people who have , say

1:00:44

, diabetes , because we're not titrating

1:00:47

down the concentration of

1:00:49

the deuterium-depleted water ? Is that correct ? Yeah ?

1:00:52

Yeah , yeah . So that

1:00:54

would be the simplest way to again help

1:00:56

the people keep

1:00:58

the blood sugar level within the range

1:01:01

, prevent blinding and

1:01:03

the amputation of the legs and all

1:01:05

the things . And

1:01:08

even I believe that somebody

1:01:10

with a diabetes would

1:01:12

consume , for example , 105 ppm

1:01:15

for three , four months . Maybe

1:01:17

they can stop drinking DW and

1:01:20

the blood sugar level will be

1:01:22

in the normal range , maybe

1:01:24

for a couple of months . After that

1:01:26

they stop drinking DW and

1:01:29

then they can come back and start again

1:01:31

drinking DW . And

1:01:33

the longer they can keep the

1:01:36

blood sugar level within the range

1:01:38

, the better they can prevent

1:01:41

all those bad

1:01:43

consequences of the high

1:01:45

blood sugar level .

1:01:47

Yes , that makes sense . And if we again

1:01:50

go back to the beginning of the episode where we talked about the mechanism

1:01:52

, it's simply improving mitochondrial function

1:01:55

and if we think about

1:01:57

metabolic diseases as a disease of

1:01:59

inefficient or broken

1:02:01

mitochondria , then giving

1:02:03

them deuterium depleted water will

1:02:07

lead to improved efficiency

1:02:09

of mitochondria and therefore improved

1:02:11

glycemia . The

1:02:13

question about diet in terms

1:02:16

of deuterium essentially

1:02:18

it sounds like a high fat carnivore

1:02:20

diet is the most deuterium depleted

1:02:22

diet . Is that correct ?

1:02:24

Yeah , I agree , yeah , sure . So

1:02:26

we recommend people , when starting

1:02:28

to drink DW at

1:02:31

the same time , change the diet

1:02:33

, some kind of ketogenic type

1:02:35

diet . I never say be

1:02:37

restrict ketogenic

1:02:40

because they cannot keep it on a

1:02:42

long term . They should find

1:02:44

the best way when they can optimize

1:02:47

it and keep it on a long

1:02:49

period of time .

1:02:50

Yeah , and Dr Boris

1:02:53

, who I talked to earlier , was talking about

1:02:55

the benefit of high

1:02:57

fat carnivore for all the reasons

1:02:59

of promoting metabolic water

1:03:01

function and optimizing

1:03:03

mitochondrial function . So to me

1:03:05

it sounds like a

1:03:08

high fat diet , ketogenic or

1:03:11

carnivore type diet would be the most optimal to

1:03:13

do in addition to drinking the deuterium

1:03:16

depleted water . For cancer or for

1:03:19

metabolic disease , yeah , I

1:03:21

fully agree , yes , yeah

1:03:23

, and

1:03:26

again , there's no reason

1:03:28

. I think I just want to make the point for my listeners is

1:03:30

that there's no reason why we can't do this

1:03:32

therapy in addition to other

1:03:35

things like exercise , like respecting

1:03:37

our circadian rhythm and our light environment . It's

1:03:40

great that this is simply just another tool

1:03:43

in the toolbox , so that's how I kind of

1:03:45

understand it to be .

1:03:46

There are a couple of things that we do

1:03:48

recommend not to do , and this

1:03:50

is very important . So , for example

1:03:52

, I sometimes I didn't understand

1:03:54

why the people do not show any improvement

1:03:57

even consuming DW , and

1:03:59

later it's turned out those who are taking

1:04:01

antioxidants on a high

1:04:03

dose that prevent

1:04:05

the efficacy of DW , and

1:04:08

this is the reason of the radicose . So

1:04:11

when we are going to trigger radicose

1:04:13

, hopefully triggering the necrosis

1:04:16

, but if they're taking vitamin

1:04:18

C , e , a , selenium , that

1:04:21

way we have the cancer cells

1:04:24

to work again DW . This is what

1:04:26

we recommend . The other we do not

1:04:28

recommend the exercises

1:04:31

and loading tests

1:04:33

, because then the

1:04:36

electricity increasing in the blood

1:04:38

, no enough oxygen

1:04:40

and all this thing . I again

1:04:42

found that those cancer patients

1:04:44

, they were fine starting

1:04:46

to doing exercise , they

1:04:49

relapsed . And the third

1:04:51

is don't sell no

1:04:53

sauna , no hot baths , because

1:04:56

again the higher body

1:04:58

temperature modified the metabolites

1:05:01

which again somehow helped

1:05:03

the cancer cells to treat

1:05:05

the challenges

1:05:08

of the DW . So

1:05:10

the drinking DW

1:05:13

and not doing

1:05:15

that , three different

1:05:17

things to optimize the efficacy of

1:05:19

DW .

1:05:20

OK , thank you for making those points . So

1:05:22

it's very common for people to come on with a laundry

1:05:25

list of supplements N-acetyl-cystine

1:05:27

, high dose vitamin C , cursatin

1:05:31

and all kinds of plant antioxidants

1:05:33

. So that point that I'll emphasize

1:05:35

is that that is going to interfere with the mechanism

1:05:38

by which deuterium-depleted water is aiding

1:05:41

in your body's clearance of the

1:05:43

cancer cells . So that

1:05:45

makes sense . And then intense

1:05:47

exercise obviously walking is OK , but

1:05:50

you're suggesting that high intensity

1:05:52

or long distance running is a bad idea

1:05:54

.

1:05:55

Yeah , we suggest walking epoxy

1:05:58

and all this thing .

1:05:59

Yes , just

1:06:02

walking and obviously avoiding sauna

1:06:04

and high temperature . And again

1:06:06

, this is if we're using deuterium-depleted

1:06:08

water in an oncology cancer

1:06:10

type setting . And

1:06:13

this is if you're drinking deuterium-depleted

1:06:15

water for longevity or metabolic

1:06:19

disease . It's not a problem yeah don't worry

1:06:21

about it , points that you'd like to

1:06:23

make that I haven't asked you about . Specifically with

1:06:25

regard to the cancer

1:06:27

protocol , what should I ? point out relating

1:06:31

to cancer protocol , anything that

1:06:33

I haven't asked you that you think the listeners should

1:06:36

know , say if they decide to

1:06:38

start drinking deuterium-depleted

1:06:40

water with a cancer diagnosis ?

1:06:43

I guess all the key points was

1:06:45

mentioned if I'm thinking about

1:06:47

. Don't drink any other type of liquid and

1:06:49

minimize the

1:06:52

intake of other liquids . We do

1:06:54

not say that you have to use

1:06:56

for cooking the DWU , but

1:07:00

reduce those

1:07:04

foods which has a high water content , of

1:07:06

course . But the key

1:07:08

issue is , if you cover 1.52

1:07:11

liter with a body weight between

1:07:13

10 kilograms to 80 , 90 kilograms

1:07:16

, that should be

1:07:19

a good dose to trigger that

1:07:21

mechanism and keep

1:07:23

drinking .

1:07:26

And in terms of sourcing reputable

1:07:28

deuterium-depleted water . As you mentioned

1:07:31

, sourcing can be a problem and this

1:07:33

can be counterfeit product

1:07:35

on the market . What would you recommend

1:07:37

in terms of where to

1:07:39

source high quality

1:07:41

, pure deuterium-depleted water ?

1:07:45

So our product caused preventive

1:07:47

and this is , I guess , the

1:07:51

first deuterium-depleted product on the world

1:07:53

. But there

1:07:56

are other types of water selling

1:07:58

. So when I started my research the world used

1:08:00

up about 1 liter deuterium-depleted water

1:08:02

for kinetic reaction . Now

1:08:04

the world used up about 500

1:08:07

tons deuterium-depleted water

1:08:09

. So we can guarantee that the

1:08:12

D level is

1:08:15

what is on the number on the product

1:08:17

. We have 125 , 105

1:08:19

, 85 , 65 , 45

1:08:22

, and 25 PPM . So that covered

1:08:24

the range which should be enough

1:08:27

to treat any kind of cancer

1:08:29

or metabolic disease

1:08:31

. We are

1:08:33

checking it . We have a GMP facility

1:08:36

. We have a laser equipment control

1:08:38

or the production

1:08:40

of the product . So

1:08:43

this is what we can guarantee . But

1:08:45

that doesn't mean that other products

1:08:48

on the market also are

1:08:50

due to depleted . But of

1:08:52

course I cannot be

1:08:55

responsible for that

1:08:57

type of water .

1:08:58

No , not at all . And

1:09:01

finally , if a patient

1:09:03

is embarking on deuterium-depleted specifically

1:09:05

for cancer , is there is

1:09:07

a facility that they can consult with that

1:09:10

you offer or that any doctors

1:09:13

that you endorse offer in terms of guiding

1:09:15

them through the protocol ?

1:09:18

So anyone who send

1:09:20

a message , write a letter freely

1:09:24

. We discuss them and we

1:09:26

help them . So

1:09:29

, and right now , within 20

1:09:31

minutes , I will have a meeting

1:09:33

with somebody from

1:09:35

the United States who is going to asking

1:09:38

about that . So

1:09:42

this is what I have been doing for 30 years

1:09:44

sharing what I

1:09:46

have already known , and

1:09:48

to involve more and

1:09:53

more people , because the more people

1:09:55

is familiar with that , the better

1:09:57

, because I hope , easier

1:10:00

and faster we can reach the aim to

1:10:02

cure cancer .

1:10:03

Yeah , that's a very , very admirable aim

1:10:05

. So thank you very much , dr

1:10:08

Schoenlein , for talking to me , and

1:10:10

I'll point everyone to your book and

1:10:12

I'll include the information in

1:10:14

the show notes , because I think

1:10:16

that is the best resource that

1:10:19

people can embark on , given that

1:10:21

there's no real practitioners

1:10:23

, especially in Australia , who are able to facilitate

1:10:25

this . So I will include

1:10:27

that information and I guess everyone is

1:10:29

up to themselves to

1:10:31

do their own research and make their

1:10:33

own decision . And I'll emphasize again that

1:10:36

we don't recommend discontinuing your oncology

1:10:38

treatment just because you're drinking deuterium

1:10:41

depleted water . So thank you very much

1:10:43

, dr Schoenlein . Thank

1:10:45

you , thank you .

1:10:46

It was , I guess , very useful talk

1:10:48

. Thank you for your kind Thank

1:10:51

you .

Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features